Abstract
BackgroundPneumoproteins are attractive biomarker candidates in systemic sclerosis (SSc) related interstitial lung disease (ILD) because they are easily obtainable and lung-specific. KL-6 and CCL-18 (PARC) have been previously reported as...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have